CYP2D6 and breast carcinoma: Despite the simplified AS system recommended by CPIC for genotype-phenotype translation, our study signals further refinement of the approach, probably considering other sources of variability such as POR and ABCB1. Future studies are also recommended to investigate the impact of the CYP2D6 genetic variations on the clinical outcome of breast cancer in Ethiopian patients.